VIVE vs. KLDO, ONCSQ, GNCA, HTGMQ, VRAYQ, TIVC, NUWE, NDRA, HSDT, and STRR
Should you be buying Viveve Medical stock or one of its competitors? The main competitors of Viveve Medical include Kaleido Biosciences (KLDO), OncoSec Medical (ONCSQ), Genocea Biosciences (GNCA), HTG Molecular Diagnostics (HTGMQ), ViewRay (VRAYQ), Tivic Health Systems (TIVC), Nuwellis (NUWE), ENDRA Life Sciences (NDRA), Helius Medical Technologies (HSDT), and Star Equity (STRR).
Kaleido Biosciences (NASDAQ:KLDO) and Viveve Medical (NASDAQ:VIVE) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, risk, profitability, analyst recommendations, valuation, earnings, dividends and community ranking.
In the previous week, Viveve Medical's average media sentiment score of 0.00 equaled Kaleido Biosciences'average media sentiment score.
Kaleido Biosciences has a beta of -0.06, meaning that its stock price is 106% less volatile than the S&P 500. Comparatively, Viveve Medical has a beta of 0.09, meaning that its stock price is 91% less volatile than the S&P 500.
Viveve Medical has higher revenue and earnings than Kaleido Biosciences.
81.6% of Kaleido Biosciences shares are held by institutional investors. 9.0% of Kaleido Biosciences shares are held by insiders. Comparatively, 5.7% of Viveve Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Viveve Medical received 257 more outperform votes than Kaleido Biosciences when rated by MarketBeat users. Likewise, 73.70% of users gave Viveve Medical an outperform vote while only 57.45% of users gave Kaleido Biosciences an outperform vote.
Summary
Viveve Medical beats Kaleido Biosciences on 5 of the 7 factors compared between the two stocks.
Get Viveve Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for VIVE and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding VIVE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Viveve Medical Competitors List
Related Companies and Tools
